Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Afina M
    Junior Member
    • May 2021
    • 1

    #1

    16S V4 reads contain high % reverse primer

    Hi everyone,

    I am running BI analysis for 16S V4 samples that was run using 515F/806R, MiSeq 300 PE. In average, all samples have more than 200k reads.

    I run bduk below to remove the primers and more than 90% reads are trimmed out which only left 20k reads which I find it weird. I checked the stats output from bbduk and all samples contains really high % of reverse primer.

    Code:
    bbduk.sh in1=${SAMPLE}_R1_001.fastq.gz in2=${SAMPLE}_R2_001.fastq.gz \
    		out1=ra_${SAMPLE}_R1.fastq out2=ra_${SAMPLE}_R2.fastq \
    		ktrim=l k=$numk mink=$mink copyundefined=t \
    		literal="GTGCCAGCMGCCGCGGTAA,GGACTACHVGGGTWTCTAAT" hdist=1 stats=${SAMPLE}_stats.txt \
    		tpe tbo
    Can anyone help to advice if this is normal? I run the tool multiple time with another 16S V4 dataset and the same thing happened. I did compare with 16S V3-V4 dataset and it only has around 40-50% primers.

    I am still not really familiar with sequencing workflow so can anyone help me how to check this?

    Thank you.
    Last edited by Afina M; 05-18-2021, 07:15 PM.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...